This Article Full Text Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scognamiglio, R. Articles by Volta, S. D. Search for Related Content PubMed PubMed Citation Articles by Scognamiglio, R. Articles by Volta, S. D.

(Circulation. 1997;96:816-820.)
© 1997 American Heart Association, Inc.

Articles

Postextrasystolic Potentiation and Dobutamine Echocardiography in Predicting Recovery of Myocardial Function After Coronary Bypass Revascularization

Roldano Scognamiglio, MD; Giuseppe Fasoli, MD; Dino Casarotto, MD; Manuela Miorelli, MD; Stefano Nistri, MD; Monica Palisi, MD; Marco Marin, MD; ; Sergio Dalla Volta, MD

From the Division of Cardiology, Department of Clinical and Experimental Medicine and the Department of Cardiac Surgery (D.C.), University of Padua (Italy).

Correspondence to R. Scognamiglio, MD, Cattedra di Cardiologia, Policlinico Universitario, Via Giustiniani 2, 30100 Padova, Italy.

Background Identification of viable but hibernating myocardium remains a relevant issue in the current era of myocardial revascularization. Echocardiography can be helpful in detecting reversible contractile dysfunction and optimizing the selection of patients for coronary bypass surgery.

Methods and Results Eighty-four consecutive candidates for bypass surgery with chronic multivessel coronary artery disease were screened, and 60 were included in this prospective study. Preoperative evaluation of a reversible contractile dysfunction in asynergic myocardial regions was performed by dobutamine infusion at 5 (low dose) and 10 (intermediate dose) µg·kg^-1·min^-1 with each stage lasting at least 5 minutes; postextrasystolic potentiation (PESP), with a coupling interval ranging from 500 to 300 ms with a progressive 10-ms decrease; or a combination of both dobutamine infusion and PESP. Sensitivity (92% versus 86%) and predictive accuracy (89% versus 84%) were higher with PESP than dobutamine (P=.009 and P=.001, respectively), but the combination did not improve sensitivity or accuracy. Dobutamine induced ischemic dysfunction in 15% of patients at the intermediate dose; however, the low dose resulted in loss of sensitivity.

Conclusions PESP echocardiography is a useful and cost-effective method to identify viable myocardium in patients with multivessel coronary disease undergoing revascularization and is more sensitive and accurate than dobutamine infusion.

Key Words: dobutamine • contractility • coronary disease • echocardiography • revascularization

This article has been cited by other articles:

				A. Pasquet, M.S. Lauer, M.J. Williams, M.-A. Secknus, B. Lytle, and T.H. Marwick Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism Eur. Heart J., January 2, 2000; 21(2): 125 - 136. [Abstract] [PDF]

				G. Mobilia, P. Zanco, A. Desideri, G. Neri, F. Alitto, G. Suzzi, F. Chierichetti, L. Celegon, G. Ferlin, and R. Buchberger T wave normalization in infarct-related electrocardiographic leads during exercise testing for detection of residual viability: comparison with positron emission tomography J. Am. Coll. Cardiol., July 1, 1998; 32(1): 75 - 82. [Abstract] [Full Text] [PDF]